相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Biochemistry and Physiology of Mitochondrial Fatty Acid beta-Oxidation and Its Genetic Disorders
Sander M. Houten et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Influence of exercise training with resveratrol supplementation on skeletal muscle mitochondrial capacity
Kristine R. Polley et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2016)
Emerging concepts in the therapy of mitochondrial disease
Carlo Viscomi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2015)
The molecular targets of resveratrol
Sameer S. Kulkarni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
The pharmacology of resveratrol in animals and humans
Eun-Jung Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology
Cara A. Timpani et al.
MEDICAL HYPOTHESES (2015)
Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy
Emma Rybalka et al.
NUTRIENTS (2015)
Metabolic effects of resveratrol: addressing the controversies
Jacob L. Bitterman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis
Vladimir Ljubicic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
The therapeutic potential of skeletal muscle plasticity in Duchenne muscular dystrophy: phenotypic modifiers as pharmacologic targets
Vladimir Ljubicic et al.
FASEB JOURNAL (2014)
Beneficial effects of resveratrol on respiratory chain defects in patients fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling
Alexandra Lopes Costa et al.
HUMAN MOLECULAR GENETICS (2014)
Experimental Studies of the Molecular Pathways Regulated by Exercise and Resveratrol in Heart, Skeletal Muscle and the Vasculature
Vernon W. Dolinsky et al.
MOLECULES (2014)
Effect of Resveratrol on Cultured Skin Fibroblasts from Patients with Oxidative Phosphorylation Defects
Boel De Paepe et al.
PHYTOTHERAPY RESEARCH (2014)
Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts
Virginie Aires et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
An Examination of Resveratrol's Mechanisms of Action in Human Tissue: Impact of a Single Dose In Vivo and Dose Responses in Skeletal Muscle Ex Vivo
Cameron B. Williams et al.
PLOS ONE (2014)
Can resveratrol help to maintain metabolic health?
Patrick Schrauwen et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2014)
Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of duchenne muscular dystrophy
Bradley S. Gordon et al.
CLINICAL NUTRITION (2013)
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Joao Tomé-Carneiro et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
The mdx mouse model as a surrogate for Duchenne muscular dystrophy
Terence A. Partridge
FEBS JOURNAL (2013)
Cellular and molecular mechanisms underlying muscular dystrophy
Fedik Rahimov et al.
JOURNAL OF CELL BIOLOGY (2013)
Genetic and cellular modifiers of oxidative stress: What can we learn from fatty acid oxidation defects?
Rikke Katrine Jentoft Olsen et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung-Jun Park et al.
CELL (2012)
Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
Jun Yoshino et al.
CELL METABOLISM (2012)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
Pharmacological targeting of mitochondrial complex I deficiency: The cellular level and beyond
Peggy Roestenberg et al.
MITOCHONDRION (2012)
Monogenic Mitochondrial Disorders
Werner J. H. Koopman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rescue of Dystrophic Skeletal Muscle by PGC-1α Involves a Fast to Slow Fiber Type Shift in the mdx Mouse
Joshua T. Selsby et al.
PLOS ONE (2012)
Muscle mitochondria and insulin resistance: a human perspective
Joris Hoeks et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis
Pablo J. Fernandez-Marcos et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Drug repositioning for orphan diseases
Divya Sardana et al.
BRIEFINGS IN BIOINFORMATICS (2011)
Species Differences in the Effects of Bezafibrate as a Potential Treatment of Mitochondrial Disorders
Fatima Djouadi et al.
CELL METABOLISM (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts
Jean Bastin et al.
HUMAN MOLECULAR GENETICS (2011)
Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular Dystrophy
Yusuke S. Hori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Estrogen related receptors (ERRs): A new dawn in transcriptional control of mitochondrial gene networks
Lillian J. Eichner et al.
MITOCHONDRION (2011)
Screening for Active Small Molecules in Mitochondrial Complex I Deficient Patient's Fibroblasts, Reveals AICAR as the Most Beneficial Compound
Anna Golubitzky et al.
PLOS ONE (2011)
Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
Catherine Moorwood et al.
PLOS ONE (2011)
Long-Term Follow-Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency
J. P. Bonnefont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Current issues regarding treatment of mitochondrial fatty acid oxidation disorders
Ute Spiekerkoetter et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease
Felix Distelmaier et al.
BRAIN (2009)
A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency
Georgianne L. Arnold et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Cellular effects of resveratrol in skeletal muscle
Amie J. Dirks Naylor
LIFE SCIENCES (2009)
Bezafibrate for an Inborn Mitochondrial Beta-Oxidation Defect
Jean-Paul Bonnefont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span
Kevin J. Pearson et al.
CELL METABOLISM (2008)
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase
Xiuyun Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders
F. Djouadi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Resveratrol stimulates AMP kinase activity in neurons
Biplab Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy
Christoph Handschin et al.
GENES & DEVELOPMENT (2007)
Pathophysiology of duchenne muscular dystrophy: Current hypotheses
Nicolas Deconinck et al.
PEDIATRIC NEUROLOGY (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy hemeostasis, and metabolism
Christoph Handschin et al.
ENDOCRINE REVIEWS (2006)
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur et al.
NATURE (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mechanism of human SIRT1 activation by resveratrol
MT Borra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Substrate-specific activation of sirtuins by resveratrol
M Kaeberlein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Muscle carnitine palmitoyltransferase II deficiency - Clinical and molecular genetic features and diagnostic aspects
M Deschauer et al.
ARCHIVES OF NEUROLOGY (2005)
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment - Third in Molecular Medicine Review Series
KJ Nowak et al.
EMBO REPORTS (2004)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
分享论文
